The clinical research study is looking to evaluate the safety and effectiveness of the Vercise™ Deep Brain Stimulation (DBS) system as a therapy for reducing some of the symptoms associated with Parkinson’s disease (PD) that are not adequately controlled with medication.

Compensation for time and travel may be available.

Participation is voluntary and you may withdraw from the study at any time, for any reason, without penalty.

Click here to see if you may qualify for the INTREPID study.